Condition: Rheumatoid Arthritis
Interventions: Drug: CP-690,550 (tasocitinib); Other: No intervention
Sponsor: Pfizer
Recruiting - verified August 2011
By ClinicalTrials.gov 
The independent gateway for the orthopaedic community. Connecting professionals and patients since 1999.